148 related articles for article (PubMed ID: 11779930)
1. Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view.
Lees KR
Stroke; 2002 Jan; 33(1):308-9. PubMed ID: 11779930
[No Abstract] [Full Text] [Related]
2. Neuroprotection is unlikely to be effective in humans using current trial designs.
Grotta J
Stroke; 2002 Jan; 33(1):306-7. PubMed ID: 11779929
[No Abstract] [Full Text] [Related]
3. Neuroprotection: establishing proof of concept in human stroke.
Davis SM; Donnan GA
Stroke; 2002 Jan; 33(1):309-10. PubMed ID: 11779931
[No Abstract] [Full Text] [Related]
4. Neuroprotection.
Lees KR
Br Med Bull; 2000; 56(2):401-12. PubMed ID: 11092089
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in pharmacologic neuroprotection.
Mantz J; Degos V; Laigle C
Eur J Anaesthesiol; 2010 Jan; 27(1):6-10. PubMed ID: 19617840
[TBL] [Abstract][Full Text] [Related]
6. [Past, present and future of neuroprotection].
Mracek J
Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
[TBL] [Abstract][Full Text] [Related]
7. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
Savitz SI; Fisher M
Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection and stroke: time for a compromise.
Young AR; Ali C; Duretête A; Vivien D
J Neurochem; 2007 Nov; 103(4):1302-9. PubMed ID: 17727635
[TBL] [Abstract][Full Text] [Related]
9. The future of basic science research and stroke: hubris and translational stroke research.
Lyden P
Int J Stroke; 2011 Oct; 6(5):412-3. PubMed ID: 21951405
[No Abstract] [Full Text] [Related]
10. Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy.
Weir CJ; Kaste M; Lees KR;
Stroke; 2004 Sep; 35(9):2111-6. PubMed ID: 15243146
[TBL] [Abstract][Full Text] [Related]
11. Acute stroke trials: strengthening the underpowered.
Furlan AJ
Stroke; 2002 Jun; 33(6):1450-1. PubMed ID: 12052967
[No Abstract] [Full Text] [Related]
12. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.
Gladstone DJ; Black SE; Hakim AM;
Stroke; 2002 Aug; 33(8):2123-36. PubMed ID: 12154275
[TBL] [Abstract][Full Text] [Related]
13. Acute stroke therapies: some unexpected challenges.
Donnan GA
Int J Stroke; 2007 Nov; 2(4):235. PubMed ID: 18705920
[No Abstract] [Full Text] [Related]
14. Neuroprotection in acute ischemic stroke: are we there yet?
Shuaib A
Int J Stroke; 2006 May; 1(2):100-1. PubMed ID: 18706053
[No Abstract] [Full Text] [Related]
15. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
[TBL] [Abstract][Full Text] [Related]
16. [Major stroke clinical trials in 2006].
Jeng JS
Acta Neurol Taiwan; 2007 Jun; 16(2):111-20. PubMed ID: 17685137
[TBL] [Abstract][Full Text] [Related]
17. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.
Savitz SI; Benatar M; Saver JL; Fisher M
Cerebrovasc Dis; 2008; 26(2):156-62. PubMed ID: 18560219
[TBL] [Abstract][Full Text] [Related]
18. NXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realized?
Fisher M
Stroke; 2006 Oct; 37(10):2651-2. PubMed ID: 16946143
[No Abstract] [Full Text] [Related]
19. Does neuroprotection improve stroke outcome?
Lees KR
Lancet; 1998 May; 351(9114):1447-8. PubMed ID: 9605797
[No Abstract] [Full Text] [Related]
20. [To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke].
Li YS
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):733-4. PubMed ID: 21092440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
